| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |